The Company's 2021 consolidated financial statements have been approved by the Board of Directors
· Issued by Sharehope Medicine Co., Ltd.
Close
Today's Information
Provided by: SHAREHOPE MEDICINE CO., LTD.
SEQ_NO
2
Date of announcement
2022/03/25
Time of announcement
14:09:19
Subject
The Company's 2021 consolidated financial
statements have been approved by the Board of Directors
Date of events
2022/03/25
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/03/25
2.Date of the audit committee approved:2022/03/25
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):3,850,027
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):833,956
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):258,451
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):267,629
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):193,428
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):232,663
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):2.04
11.Total assets end of the period (thousand NTD):6,112,808
12.Total liabilities end of the period
(thousand NTD):2,229,514
13.Equity attributable to owners of parent end of the
period (thousand NTD):3,148,802
14.Any other matters that need to be specified:None
